Janus kinase deregulation in leukemia and lymphoma

Chen, Edwin, Staudt, Louis M., Green, Anthony R.·2012·Immunity
DOI 10.1016/j.immuni.2012.03.017

Cited by (125)

Items 101–125 of 125

  1. Clonality in haematopoietic stem cell ageing
    Maria Terradas-Terradas, Neil Robertson, Tamir Chandra, Kristina Kirschner · 2020 · Mechanisms of Ageing and Development
  2. Enhanced T Cell Lymphoma in NOD.Stat5b Transgenic Mice Is Caused by Hyperactivation of Stat5b in CD8+ Thymocytes
    Bo Chen, Bing Yi, Rui Mao, Haitao Liu, Jinhua Wang, Ashok Kumar Sharma, Stephen S. Peiper, Warren J. Leonard, Jin‐Xiong She · 2013 · PLoS ONE
  3. Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy
    Xia Zhao, Wei Zhang, Li Wang, Weili Zhao · 2013 · Biomarker Research
  4. Stem and Progenitor Cell Subsets Are Affected by JAK2 Signaling and Can Be Monitored by Flow Cytometry
    Ryuji Iida, Robert S. Welner, Wanke Zhao, José Alberola‐Ila, Kay L. Medina, Zhizhuang Joe Zhao, Paul W. Kincade · 2014 · PLoS ONE
  5. HiJAKing the epigenome in leukemia and lymphoma
    Amanda C. Drennan, Lixin Rui · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
  6. Molecular basis of JAK kinase regulation guiding therapeutic approaches: Evaluating the JAK3 pseudokinase domain as a drug target
    Anniina T. Virtanen, Vivian Kettunen, Kirsikka Musta, Veera Räkköläinen, Stefan Knapp, T. Haikarainen, Olli Silvennoinen · 2024 · Advances in Biological Regulation
  7. BCR–JAK2 drives a myeloproliferative neoplasm in transplanted mice
    Álvaro Cuesta‐Domínguez, Diego León‐Rico, Lara A. Alvarez, Begoña Díez, Irene Bodega‐Mayor, Rocío Baños, Miguel Ángel Martín‐Rey, Matilde Santos‐Roncero, Marı́a-Luisa Gaspar, Paloma Martín et al. · 2015 · The Journal of Pathology
  8. Ex Vivo Transposon-Mediated Genetic Screens for Cancer Gene Discovery
    Kathryn A. O’Donnell, Yabin Guo, Shruthy Suresh, Barrett L. Updegraff, Xiaorong Zhou · 2018 · Methods in molecular biology
  9. Citicoline modulates inflammatory signaling pathways in the spleen of rats exposed to gamma-radiation
    Nahed Abdel-Aziz, Mostafa Saif‐Elnasr · 2024 · Immunopharmacology and Immunotoxicology
  10. Beyond monotherapy: multimodal strategies integrating immune checkpoint inhibitors in lymphoma management
    Yuxiao Li, Ruixin Zheng, Bing Pan, Xiaobo Wang, Lina Zhang, Haiying Gao, Li Li · 2025 · Frontiers in Immunology
  11. In silico analysis of Missense Variants in Human MPL Gene Associated with Essential Thrombocythemia
    Sahar G. Elbager, Abier Abdelaziz Makkawi Abdelrahman, Hadeel A. Mohamed, Fauzia A. Abdelrahman, Lamia H. Osman, Moroj F. Hameed, Asia M. Elrashid, Mohamed Y. Basher, Safinaz I. Khalil, Magdi Bayoumi · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  12. A Structural Perspective on Non-covalent Targeting of Conserved Polar Residues in Protein Kinases
    Nader N. Nasief, Kishan B. Patel, Blessing C. Ogboo, David E. Heppner · 2026 · Journal of Medicinal Chemistry
  13. Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways
    Ksenija I. Zarubina, Elena Nikolaevna Parovichnikova, В. Л. Сурин, Olesya S. Pshenichnikova, Olga A. Gavrilina, Galina A. Isinova, Vera V. Troitskaya, Andrey Nikolaevich Sokolov, Irina Vladimirovna Galtseva, Капранов Николай Михайлович et al. · 2020 · Terapevticheskii arkhiv
  14. Maintenance of haematopoietic stem cells by JAK inhibition and increased tyrosine-unphosphorylated STAT5
    Matthew Williams, Xiaonan Wang, Hugo P. Bastos, Gabriela Grondys-Kotarba, Carys S. Johnson, Nicole Mende, Emily F. Calderbank, Michelle Wantoch, Hyun Jung Park, Qin Wu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Avaliação da cinética de expressão in vitro de STATs em linfócitos humanos e sua correlação com secreção de citocinas e expressão de seus respectivos receptores
    Susana Lima Lessa Lôbo · 2014
  16. Myeloproliferative Neoplasms – Molecular Biology and Potential Targets for Intervention
    2014 · BENTHAM SCIENCE PUBLISHERS eBooks
  17. The myeloma bone marrow environment and survival signaling
    Asim Khwaja, John Quinn, Kwee Yong · 2013 · Cambridge University Press eBooks
  18. Aberrant Transcriptional Programming in Blood Cancers
    Constanze Bonifer, Peter N. Cockerill, Anetta Ptasinska · 2015 · Springer eBooks
  19. Inhalational Delivery of a JAK3 Inhibitor for the Novel Treatment of Asthma and the Investigation of Pharmaceutical Salts in HFA Propellant Systems
    Usir S. Younis · 2018 · UA Campus Repository (The University of Arizona)
  20. JAK, an Oncokinase in Hematological Cancer
    Carlota Recio, Haidée Aranda-Tavío, Miguel Guerra-Rodríguez, Mercedes de Mirecki-Garrido, Patricia Martin‐Rodríguez, Borja Guerra, Leandro Fernández‐Pérez · 2019 · IntechOpen eBooks
  21. CXCL7 plays a crucial role in facilitating extramedullary invasion and osteolytic damage in multiple myeloma
    Peng Liu, Yue Wang, Tianwei Lan, Chi Zhou · 2024 · Research Square
  22. JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells
    Jeremy Deuel, Andrejs Makarovs, Sheidasadat Goosheh, George Winder, Hisham Mohammed, Jason S. Carroll, Michael Spencer Chapman, Chiraag D. Kapadia, Peter Campbell, Jyoti Nangalia et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Molecular thermodynamic aspects of dissipative structures in oncology, inflammatory and degenerative processes of Central Nervous System diseases
    Alexandre Vallée · 2017 · theses.fr (ABES)
  24. BindingDB Entry 50016738: Conversion of a False Virtual Screen Hit into Selective JAK2 JH2 Domain Binders Using Convergent Design Strategies.
    BindingDB · 2023 · UC San Diego
  25. BindingDB Entry 50009949: The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3.
    BindingDB · 2021 · UC San Diego